New Math Model Reveals Stem Cell Dynamics Drive Epigenetic Aging Across Mammals
A unified mathematical model shows stem cell division rates — not methylation errors — explain why longer-lived species age more slowly.
Summary
Scientists have built a mathematical model called SCARLET that explains how DNA methylation changes — the basis of biological age clocks — actually arise from stem cell behavior in the blood. Instead of treating different methylation patterns as separate phenomena, SCARLET shows they all stem from one underlying process: how often hematopoietic stem cells divide relative to the size of the stem cell pool. People who age faster biologically have a lower ratio of stem cell pool size to division rate. Remarkably, when the model was applied to 11 mammalian species, this same ratio scaled with maximum lifespan — meaning long-lived species maintain a larger, more slowly dividing stem cell pool. This reframes epigenetic aging not as a failure of cellular maintenance, but as an evolutionary tuning of stem cell dynamics.
Detailed Summary
DNA methylation clocks are among the most powerful tools in aging research, reliably predicting biological age and disease risk. Yet the biological mechanisms driving these methylation changes have remained poorly understood — until now.
Researchers from Mayo Clinic and the University of Edinburgh developed SCARLET (Stem Cells and Age-ReLated Epigenetic Trajectories), a mathematical model describing how age-related methylation changes originate and spread through hematopoietic stem cell (HSC) divisions. Rather than treating various methylation drift patterns as independent phenomena, SCARLET demonstrates they are all manifestations of a single unifying process rooted in stem cell biology.
Using a large human cohort, the team showed that individuals with accelerated epigenetic aging consistently display a lower ratio of stem cell pool size to division rate (N/s). In other words, biological aging is faster when stem cells divide more frequently relative to pool size — amplifying methylation errors with each replication cycle.
The model's reach extended beyond humans. When applied to methylation datasets from 11 mammalian species, SCARLET revealed that the N/s ratio scales with maximum lifespan. Longer-lived mammals appear to have evolved larger or more slowly cycling HSC pools, not simply better molecular proofreading machinery. This challenges the prevailing assumption that epigenetic maintenance efficiency is the primary determinant of species lifespan.
The implications are significant. If stem cell dynamics are the true upstream driver of epigenetic aging clocks, then interventions that modulate HSC division rates or pool size — rather than targeting methylation patterns directly — may more fundamentally slow biological aging. However, this study is based on the abstract only, and full methodological details, effect sizes, and model validation specifics await complete publication review.
Key Findings
- SCARLET model unifies all major age-related methylation patterns under a single stem cell dynamics framework.
- Accelerated biological aging correlates with a lower ratio of stem cell pool size to division rate (N/s).
- The N/s ratio scales with maximum lifespan across 11 mammalian species studied.
- Evolutionary lifespan differences likely reflect stem cell dynamics, not epigenetic maintenance efficiency.
- Findings suggest modulating HSC division rates could be a target for slowing epigenetic aging.
Methodology
The SCARLET mathematical model was validated against a large human cohort to explain blood-based DNA methylation trajectories across age. Researchers then applied the model cross-species to methylation data from 11 mammalian species to test whether stem cell dynamics parameters predict maximum lifespan. Study published in Nature Aging ahead of print in May 2026.
Study Limitations
This summary is based on the abstract only, as the full paper is not open access; key methodological details, statistical effect sizes, and model validation specifics are not available for review. The model focuses on blood-derived methylation and hematopoietic stem cells, so its applicability to other tissues and non-hematopoietic aging processes is unclear. Cross-species comparisons rely on available methylation datasets, which may vary in quality and sample size across the 11 species included.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.